Cargando…

Deep Drug Discovery of Mac Domain of SARS-CoV-2 (WT) Spike Inhibitors: Using Experimental ACE2 Inhibition TR-FRET Assay, Screening, Molecular Dynamic Simulations and Free Energy Calculations

SARS-CoV-2 exploits the homotrimer transmembrane Spike glycoproteins (S protein) during host cell invasion. The Omicron XBB subvariant, delta, and prototype SARS-CoV-2 receptor-binding domain show similar binding strength to hACE2 (human Angiotensin-Converting Enzyme 2). Here we utilized multiligand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iqbal, Saleem, Lin, Sheng-Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451221/ https://www.ncbi.nlm.nih.gov/pubmed/37627846 http://dx.doi.org/10.3390/bioengineering10080961

Ejemplares similares

SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET
por: Cecon, Erika, et al.
Publicado: (2022)

Detection of SARS-CoV-2 spike protein binding to ACE2 in living cells by TR-FRET
por: Cecon, Erika, et al.
Publicado: (2021)

SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening
por: Gorshkov, Kirill, et al.
Publicado: (2022)

A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening
por: Gorshkov, Kirill, et al.
Publicado: (2021)

Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening
por: Zhang, Feng-cai, et al.
Publicado: (2019)

Quantifying autophagy using novel LC3B and p62 TR-FRET assays
por: Bresciani, Alberto, et al.
Publicado: (2018)

Optimization and validation of a DYRK1A TR-FRET assay for high-throughput screening
por: Tarpley, Michael, et al.
Publicado: (2021)

Synergistic FRET assays for drug discovery targeting RyR2 channels
por: Rebbeck, RobynT., et al.
Publicado: (2022)

Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation
por: Hermanson, Spencer B., et al.
Publicado: (2012)

TR-FRET Assays of Huntingtin Protein Fragments Reveal Temperature and PolyQ Length-Dependent Conformational Changes
por: Cui, Xiaotian, et al.
Publicado: (2014)

Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay
por: Watari, Akihiro, et al.
Publicado: (2017)

A protocol for high-throughput screening of histone lysine demethylase 4 inhibitors using TR-FRET assay
por: Wu, Qiong, et al.
Publicado: (2021)

The Use of the LanthaScreen TR-FRET CAR Coactivator Assay in the Characterization of Constitutive Androstane Receptor (CAR) Inverse Agonists
por: Carazo, Alejandro, et al.
Publicado: (2015)

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
por: Badraoui, Riadh, et al.
Publicado: (2021)

Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2
por: Lima, Marcelo A., et al.
Publicado: (2021)

TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2
por: Bux, Jessica, et al.
Publicado: (2023)

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
por: Heinzelman, Pete, et al.
Publicado: (2020)

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
por: Heinzelman, Pete, et al.
Publicado: (2021)

Single-Peptide TR-FRET Detection Platform for Cysteine-Specific Post-Translational Modifications
por: Eskonen, Ville, et al.
Publicado: (2020)

Accommodating receptor flexibility and free energy calculation to reduce false positive binders in the discovery of natural products blockers of SARS-COV-2 spike RBD-ACE2 interface
por: Ogedjo, Marcelina, et al.
Publicado: (2021)

Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
por: Olaleye, Omonike A., et al.
Publicado: (2021)

Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay
por: Dražić, Tonko, et al.
Publicado: (2021)

A 15-min non-competitive homogeneous assay for microcystin and nodularin based on time-resolved Förster resonance energy transfer (TR-FRET)
por: Akter, Sultana, et al.
Publicado: (2021)

Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3
por: Virdi, Rajdeep S., et al.
Publicado: (2020)

Calculation of AeroMACS Spectrum Requirements Based on Traffic Simulator
por: Shin, Hong-Gi, et al.
Publicado: (2021)

Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
por: Levy, Yinon, et al.
Publicado: (2022)

Demonstration of LanthaScreen™ TR-FRET-based nuclear receptor coactivator recruitment assay using PHERAstar, a multi-detection HTS microplate reader
por: D'Souza, Prashanth C.G., et al.
Publicado: (2008)

Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity
por: Phelan, Thomas, et al.
Publicado: (2021)

Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2
por: Zhao, Min, et al.
Publicado: (2021)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2
por: Wang, Shunxin, et al.
Publicado: (2008)

Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor
por: Mahalingam, Gokulnath, et al.
Publicado: (2023)

Single-Molecule FRET Imaging of Virus Spike–Host Interactions
por: Lu, Maolin
Publicado: (2021)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination
por: Abdul, Fabien, et al.
Publicado: (2022)

Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain
por: Bernardi, Austen, et al.
Publicado: (2020)

Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein
por: Ma, Shaojie, et al.
Publicado: (2021)

FRET-based hACE2 receptor mimic peptide conjugated nanoprobe for simple detection of SARS-CoV-2
por: Kang, Byunghoon, et al.
Publicado: (2022)

WT1 and ACE mRNAs of blood extracellular vesicle as biomarkers of diabetic nephropathy
por: Hashemi, Ehsan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_22ft7mj8pleemcmvf22vn4b3bg